David D. Davidar - Sep 13, 2024 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
Director
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Stock symbol
GMED
Transactions as of
Sep 13, 2024
Transactions value $
-$1,123,500
Form type
4
Date filed
9/17/2024, 04:31 PM
Previous filing
May 10, 2024
Next filing
Oct 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $638K +25K +4.41% $25.52 591K Sep 13, 2024 Direct
transaction GMED Class A Common Stock Sale -$1.76M -25K -4.23% $70.46 566K Sep 13, 2024 Direct F1
holding GMED Class A Common Stock 206K Sep 13, 2024 By Davidar Family Irrevocable Trust U/A 8/6/09 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -25K -50% $0.00 25K Sep 13, 2024 Class A Common Stock 25K $25.52 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at a price range of $70.20 - $70.80, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4.
F2 These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.
F3 These options were granted on January 25, 2016 and are fully vested.